Participants 83 131 5
patients with advanced nasopharyngeal carcinoma:
Participants 281 335 4
patients with advanced nasopharyngeal carcinoma (NPC).
Participants 344 474 8
Two hundred patients with stage III/IV NPC were randomly allocated into the treatment group (N=100) and the control group (N=100).
